References
- Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: HJ Maier, E Bickerton, P Britton, editor. Coronaviruses. New York: Humana Press; 2015. p. 1–23.
- Kahn JS, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J. 2005;24:223–227.
- Cavanagh D, Mawditt K, Sharma M, et al. Detection of a coronavirus from Turkey poults in Europe genetically related to infectious bronchitis virus of chickens. Avian Pathol. 2001;30:355–368.
- Teixeira MCB, Luvizotto MCR, Ferrari HF, et al. Detection of Turkey coronavirus in commercial Turkey poults in Brazil. Avian Pathol. 2007;36:29–33.
- Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281–286.
- WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. 2020 [cited 2020 Oct 13]. Available from: https://covid19.who.int/.
- Richman DD, Whitley RJ, Hayden FG, editors. Clinical virology. 4th ed. US: John Wiley & Sons; 2016.
- Neuman BW, Adair BD, Yoshioka C, et al. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J Virol. 2006;80:7918–7928.
- Chen W, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473.
- Malik YS, Sircar S, Bhat S, et al. Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q. 2020;40:68–76.
- Anjum FR, Anam S, Rahman SU. Novel coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries. Hum Vaccin Immunother. 2020:1–3.
- Gorbalenya AE, Baker SC, Baric RS, et al. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544.
- WHO Director-General’s opening remarks at the media briefing on COVID-19, 11 March 2020 [Internet]. 2020 [cited 2020 Aug 1]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
- Biswas A, Bhattacharjee U, Chakrabarti AK, et al. Emergence of novel coronavirus and COVID-19 : whether to stay or die out ? Crit Rev Microbiol. 2020;46:182–193.
- Liu Y, Gayle AA, Wilder-Smith A, et al. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27:1–4.
- Coronavirus Symptoms (COVID-19) [Internet]. 2020 [cited 2020 Aug 1]. Available from: https://www.worldometers.info/coronavirus/coronavirus-symptoms/.
- Wang L, Wang Y, Ye D, et al. A review of the 2019 novel coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents. 2020;55:105948.
- Columbus C, Brust KB, Arroliga AC. 2019 novel coronavirus: an emerging global threat. Baylor Univ Med Cent Proc. 2020;33:209–212.
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. jama. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
- Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92:577–583.
- Gautier JF, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity. 2020;28:848.
- Cherry G, Rocke J, Chu M, et al. Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends. Expert Rev Anti Infect Ther. 2020;18:1–6. doi:10.1080/14787210.2020.1792289.
- Boscolo-Rizzo P, Borsetto D, Fabbris C, et al. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Neck Surg. 2020;1:8–11.
- Mojtaba KA, Nahid J, Kambiz E. Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report. Infect Dis. 2020;0:1–3.
- Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088–1095.
- Coronavirus disease (COVID-19) advice for the public: myth busters [Internet]. 2020 [cited 2020 Jun 2]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters.
- Vellingiri B, Jayaramayya K, Iyer M, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277.
- Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14:58–60.
- Huang M, Tang T, Pang P, et al. Treating COVID-19 with Chloroquine. J Mol Cell Biol. 2020;12:322–325.
- Andrea C, Ingoglia G, Ippolito M, et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020;57:279–283.
- Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14:72–73.
- Al-Tawfiq JA, Al-Homoud AH, Memish ZA. Remdesivir as a possible therapeutic option for the COVID-19. Travel Med Infect Dis. 2020;34:101615.
- Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382:2327–2336.
- Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19—preliminary report. N Engl J Med. 2020;383:1–12.
- Hendaus MA. Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary. J Biomol Struct Dyn. 2020;38:1–10.
- Cai Q, Yang M, Liu D, et al. Experimental treatment with Favipiravir for COVID-19: an open-Label Control study. Engineering. 2020: 1–7. doi:10.1016/j.eng.2020.03.007.
- Hung IFN, Lung KC, Tso EYK, et al. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395:1695–1704.
- Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020;382:1787–1799.
- Ektorp E. Death threats after a trial on chloroquine for COVID-19. Lancet Infect Dis. 2020;20:661.
- Guastalegname M, Vallone A. Could Chloroquine / Hydroxychloroquine Be Harmful in coronavirus disease 2019 (COVID-19) treatment? Clin Infect Dis. 2020;71:888–889.
- Girija PLT, Sivan N. Ayurvedic treatment of COVID-19/ SARS-CoV-2: a case report. J Ayurveda Integr Med. 2020. 10.1016/j.jaim.2020.06.001.
- Golechha M. Time to realise the true potential of Ayurveda against COVID-19. Brain Behav Immun. 2020;87:130–131.
- Rastogi S, Pandey DN, Singh RH. COVID-19 pandemic: a pragmatic plan for ayurveda intervention. J Ayurveda Integr Med. 2020: 1–4. doi:10.1016/j.jaim.2020.04.002.
- Tillu G, Chaturvedi S, Chopra A, et al. Public health approach of Ayurveda and Yoga for COVID-19 Prophylaxis. J Altern Complement Med. 2020;26:360–364.
- Shahrajabian MH, Sun W, Shen H, et al. Chinese herbal medicine for SARS and SARS-CoV-2 treatment and prevention, encouraging using herbal medicine for COVID-19 outbreak. Acta Agric Scand Sect B Soil Plant Sci. 2020;70:437–443.
- Luo H, Tang Q, Shang Y, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26:243–250.
- Cots JM, Alós J, Bárcena M, et al. Traditional Chinese medicine treatment of COVID-19. Complement Ther Clin Pract. 2020;39:101165.
- Li Y, Liu X, Guo L, et al. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-Analysis. Syst Rev. 2020;9:1–6.
- Maideen NMP. Prophetic medicine-Nigella Sativa (Black cumin seeds) – potential herb for COVID-19? J Pharmacopuncture. 2020;23:62–70.
- Rahman MT. Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19. J Herb Med. 2020;23:100382.
- Kulyar MF-A, Li R, Mehmood K, et al. Potential influence of Nagella sativa (Black Cumin) in reinforcing immune system: a hope to decelerate the COVID-19 pandemic. Phytomedicine. 2020.doi:10.1016/j.phymed.2020.153277.
- Asadi S, Bouvier N, Wexler AS, et al. The coronavirus pandemic and aerosols: does COVID-19 transmit via expiratory particles? Aerosol Sci Technol. 2020;54:635–638.
- Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2020;38:1–10. doi:10.1080/07391102.2020.1758788.
- Barker J, Stevens D, Bloomfield SF. Spread and prevention of some common viral infections in community facilities and domestic homes. J Appl Microbiol. 2001;91:7–21.
- von Rheinbaben F, Schunemann S, Gross T, et al. Transmission of viruses via contact in a household setting: experiments using bacteriophage phi X174 as a model virus. J Hosp Infect. 2000;46:61–66.
- Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread of norovirus contamination via environmental surfaces. J Hosp Infect. 2004;58:42–49.
- Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104:246–251.
- Vasickova P, Pavlik I, Verani M, et al. Issues concerning survival of viruses on surfaces. Food Environ Virol. 2010;2:24–34.
- Neeltje van D, Morris DH, Holbrook MG, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567.
- Behzadinasab S, Chin A, Hosseini M, et al. A surface coating that rapidly Inactivates SARS-CoV-2. ACS Appl Mater Interfaces. 2020;12:34723–34727.
- Chin AWH, Chu JTS, Perera MRA, et al. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020;1:E10.
- Raha S, Mallick R, Basak S, et al. Is copper beneficial for COVID-19 patients? Med Hypotheses. 2020;142:109814.
- Sizun J, Yu MWN, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces : a possible source of hospital-acquired infections. J Hosp Infect. 2000;46:55–60.
- Duan SM, Zhao XS, Wen RF, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci. 2003;16:246–255.
- Van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill. 2013;18:1–4.
- Warnes SL, Little ZR, Keevil CW. Human coronavirus 229E remains infectious on common touch surface materials. MBio. 2015;6:1–10.
- Rabenau HF, Cinatl J, Morgenstern B, et al. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1–6.
- Lai MYY, Cheng PKC, Lim WWL. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis. 2005;41:67–71.
- Fujimori Y, Sato T, Hayata T, et al. Novel antiviral characteristics of nanosized copper(i) iodide particles showing inactivation activity against 2009 pandemic H1N1 influenza virus. Appl Environ Microbiol. 2012;78:951–955.
- Chan KH, Peiris JSM, Lam SY, et al. The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol. 2011;2011:1–7.
- Darnell MER, Subbarao K, Feinstone SM, et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004;121:85–91.
- Torres AE, Lyons AB, Narla S, et al. Ultraviolet-C and other methods of respirators during the COVID-19 pandemic. Photochem Photobiol Sci. 2020;19:746–751.
- Shirbandi K, Barghandan S, Mobinfar O, et al. Inactivation of coronavirus with ultraviolet irradiation: what? How? Why? SSRN. 2020. doi:10.2139/ssrn.3571418.
- Leclercq I, Batéjat C, Burguière AM, et al. Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza Other Respi Viruses. 2014;8:585–586.
- Pawar D, Adsul B, Bhalla R, et al. Use of steam as adjuvant-treatment in covid-19 patients : an observational study. Ind Med Gaz. 2020: 1–2.
- Brewster CT, Choong J, Thomas C, et al. Steam inhalation and paediatric burns during the COVID-19 pandemic steam. Lancet. 2020;395:1690.
- Ratnesar-Shumate S, Williams G, Green B, et al. Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces. J Infect Dis. 2020;222:214–222.
- News: Copper masks — a hopeful weapon against COVID-19 [Internet]. Univ. Massachusetts Amherst. 2020 [cited 2020 Jun 2]. Available from: https://www.cns.umass.edu/news-events/news/copper-masks-hopeful-weapon-against-covid-19.
- Maryon EB, Molloy SA, Zimnicka AM, et al. Copper entry into human cells: progress and unanswered questions. BioMetals. 2007;20:355–364.
- Kaplan JH, Maryon EB. How mammalian cells acquire copper: an essential but potentially toxic metal. Biophys J. 2016;110:7–13.
- Ren G, Hu D, Cheng EWC, et al. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents. 2009;33:587–590.
- Nilsson JO, Törnkvist C, Liedberg B. Photoelelctron and infrared reflection absorption spectroscopy of benzotriazole adsorbed on copper and cufrous oxide surfaces. Appl Surf Sci. 1989;37:306–326.
- Ishiguro H, Nakano R, Yao Y, et al. Photocatalytic inactivation of bacteriophages by TiO2-coated glass plates under low-intensity, long-wavelength UV irradiation. Photochem Photobiol Sci. 2011;10:1825–1829.
- Kikuchi Y, Sunada K, Iyoda T, et al. Photocatalytic bactericidal effect of TiO2 thin films: dynamic view of the active oxygen species responsible for the effect. J Photochem Photobiol A Chem. 1997;106:51–56.
- Kaur A, Anderson WA, Tanvir S, et al. Solar light active silver/iron oxide/zinc oxide heterostructure for photodegradation of ciprofloxacin, transformation products and antibacterial activity. J Colloid Interface Sci. 2019;557:236–253.
- Sim W, Barnard RT, Blaskovich MAT, et al. Antimicrobial silver in medicinal and consumer applications: a patent review of the past decade (2007–2017). Antibiotics. 2018;7:1–15.
- Galdiero S, Falanga A, Cantisani M, et al. Silver nanoparticles as novel antibacterial and antiviral Agents. Handb Nanobiomedical Res. 2014;1:565–594.
- Clement JL, Jarrett PS. Antibacterial silver. Met Based Drugs. 1994;1:467–482.
- Galdiero S, Falanga A, Vitiello M, et al. Silver nanoparticles as potential antiviral agents. molecules . 2011;16:8894–8918.
- Furno F, Morley KS, Wong B, et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother. 2004;54:1019–1024.
- Trefry JC. The development of silver nanoparticles as antiviral agents. Ohio: Wright State University; 2011.
- Mori Y, Ono T, Miyahira Y, et al. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett. 2013;8:1–6.
- Minoshima M, Lu Y, Kimura T, et al. Comparison of the antiviral effect of solid-state copper and silver compounds. J Hazard Mater. 2016;312:1–7.
- Orlowski P, Tomaszewska E, Gniadek M, et al. Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS One. 2014;9:1–15.
- Rogers J V, Parkinson C V, Choi YW, et al. A preliminary assessment of silver nanoparticle inhibition of Monkeypox virus plaque formation. Nanoscale Res Lett. 2008;3:129–133.
- Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;3:1–10.
- Joe YH, Park DH, Hwang J. Evaluation of Ag nanoparticle coated air filter against aerosolized virus : anti-viral efficiency with dust loading. J Hazard Mater. 2016;301:547–553.
- Park S, Ko Y, Jung H, et al. Disinfection of waterborne viruses using silver nanoparticle-decorated silica hybrid composites in water environments. Sci Total Environ. 2018;625:477–485.
- De Gusseme B, Sintubin L, Baert L, et al. Biogenic silver for disinfection of water contaminated with viruses. Appl Environ Microbiol. 2010;76:1082–1087.
- Zodrow KR. Polysulfone ultrafiltration membranes impregnated with silver nanoparticles show improved biofouling resistance and virus removal. Houston, Texas: RICE Univeristy; 2009.
- Palmieri V, Papi M. Can graphene take part in the fight against COVID-19 ? Nano Today. 2020;33:100883.
- Sametband M, Kalt I, Gedanken A, et al. Herpes Simplex Virus Type-1 attachment inhibition by functionalized graphene oxide. Appl Mater Interfaces. 2014;6:1228–1235.
- Ziem B, Azab W, Gholami MF, et al. Size-dependent inhibition of Herpesvirus Cellular Entry by Polyvalent Nanoarchitectures. Nanoscale. 2017;9:3774–3783.
- Ziem B, Thien H, Achazi K, et al. Highly efficient multivalent 2D nanosystems for inhibition of orthopoxvirus particles. Adv Healthc Mater. 2016;5:2922–2930.
- Ye S, Shao K, Li Z, et al. Antiviral activity of graphene oxide : how sharp edged structure and charge matter. Appl Mater Interfaces. 2015;7:21571–21579.
- Song Z, Wang X, Zhu G, et al. Virus capture and destruction by label-free graphene oxide for detection and disinfection applications. Small. 2015;11:1171–1176.
- Chen Y, Hsueh Y, Hsieh C, et al. Antiviral activity of graphene – silver nanocomposites against non-enveloped and enveloped viruses. Int J Environ Res Public Health. 2016;13:1–12.
- Huang K, Li Z, Lin J, et al. Two-dimensional transition metal carbides and nitrides (MXenes) for biomedical applications. Chem Soc Rev. 2018;47:5109–5124.
- Rasool K, Helal M, Ali A, et al. Antibacterial activity of Ti3C2TX MXene. ACS Nano. 2016;10:3674–3684.
- Rasool K, Mahmoud KA, Johnson DJ, et al. Efficient antibacterial membrane based on two-dimensional Ti3C2Tx (MXene) nanosheets. Sci Rep. 2017;7:1–11.
- Chen C, Boota M, Urbankowski P, et al. Effect of glycine functionalization of 2D titanium carbide (MXene) on charge storage. Mater Chem A. 2018;6:4617–4622.
- Dowd KO, Nair KM, Forouzandeh P, et al. Face masks and respirators in the fight against the COVID-19 pandemic: a review of current materials, advances and future perspectives. Materials. 2020;13:3363), doi:10.3390/ma13153363.
- New face masks use graphene and electrical charge to repel viruses and bacteria [Internet]. 2020 [cited 2020 Jun 11]. Available from: https://www.graphene-info.com/new-face-masks-use-graphene-and-electrical-charge-repel-viruses-and-bacteria.
- Wash Resistant Anti-viral & Anti-bacterial Coated Masks and Textile [Internet]. 2020. Available from: https://www.ants-duraprot.com/wp-content/uploads/2020/07/Duraprot-Tests-1.pdf.
- Quan F, Rubino I, Lee S, et al. Universal and reusable virus deactivation system for respiratory protection. Sci Rep. 2017;7:1–10.
- A biomedical engineer created a mask coated in salt that he says could neutralize viruses like the coronavirus in 5 minutes [Internet]. 2020. Available from: https://www.businessinsider.in/science/news/a-biomedical-engineer-created-a-mask-coated-in-salt-that-he-says-could-neutralize-viruses-like-the-coronavirus-in-5-minutes/articleshow/74029912.cms.
- Li Y, Leung P, Yao L, et al. Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect. 2006;62:58–63.
- Mustafa Z, Ghaffari M. What do we need to know to improve diagnostic testing methods for the 2019 novel coronavirus? Cureus. 2020;12:10–15.
- Rabiee N, Bagherzadeh M, Ghasemi A, et al. Point-of-use rapid detection of SARS-CoV-2 : nanotechnology-enabled solutions for the COVID-19 pandemic. Int J Mol Sci. 2020;21:5126), doi:10.3390/ijms21145126.
- Pokhrel P, Hu C, Mao H. Detecting the coronavirus (COVID-19). ACS Sensors. 2020;5:2283–2296.
- Jung JH, Cheon DS, Liu F, et al. A graphene oxide based immuno biosensor for pathogen detection. Angew Chemie. 2010;49:5708–5711.
- Xie Z, Huang J, Luo S, et al. Ultrasensitive electrochemical immunoassay for Avian influenza Subtype H5 using Nanocomposite. PLoS One. 2014;9:96–99.
- Huang J, Xie Z, Xie Z, et al. Silver nanoparticles coated graphene electrochemical sensor for the ultrasensitive analysis of avian influenza virus H7. Anal Chim Acta. 2016;913:121–127.
- Singh R, Hong S, Jang J. Label-free detection of influenza viruses using a reduced graphene oxide-based electrochemical immunosensor integrated with a microfluidic platform. Sci Rep. 2017;7:1–11.
- Tu Z, Guday G, Adeli M, et al. Multivalent interactions between 2D nanomaterials and biointerfaces. Adv Mater. 2018;1706709:1–27.
- Stoimenov PK, Klinger RL, Marchin GL, et al. Metal oxide nanoparticles as bactericidal agents. Langmuir. 2002;18:6679–6686.
- Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16:2346–2353.
- Seo G, Lee G, Kim MJ, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14:5135–5142.
- Huang C, Wen T, Shi FJ, et al. Rapid detection of IgM antibodies against the SARS-CoV-2 virus via colloidal gold nanoparticle-based lateral-flow assay. ACS Omega. 2020;5:12550–12556.
- Moitra P, Alafeef M, Dighe K, et al. Selective naked-Eye detection of SARS-CoV -2 mediated by N gene targeted antisense oligonucleotide capped plasmonic nanoparticles. ACS Nano. 2020;14:7617–7627.
- Prakash MK, Kaushal S, Bhattacharya S, et al. Minimal and adaptive numerical strategy for critical resource planning in a pandemic. Phys Rev E. 2020;102:1–7.